Thousands of Dutch patients are facing a 10-month supply gap for medically essential Bedrocan products, including varieties clinicians consider irreplaceable for children with treatment-resistant ...
Germany’s coalition government has retreated further on its controversial medical cannabis reimbursement reforms as it faces mounting questions over how and why the law came to be. A swathe of ...
Irish active-ingredient manufacturer Dunbar Pharmaceuticals has launched the UK’s first plant-derived dronabinol oral spray, extending a pharma-grade THC line that reached specialist prescribers in ...
The highly anticipated Advisory Council on the Misuse of Drugs (ACMD) review into the UK’s medical cannabis framework has, for the first time, received a new target publication date. In an update to ...
Dr Nickel Dittrich is Managing Director of GMPion, a Berlin-based EU-GMP consultancy. Before founding GMPion, he spent more than five years at Cantourage, where he led the EU-GMP audit process for ...
James Duckenfield, CEO of Glass Pharms®, explains why we may be underestimating the pharmaceutical potential of cannabis, and how research, formulation… ...
As Chief Administrative Law Judge Derek Julius weighs his recommendation on moving cannabis to Schedule III, the DEA’s own closing brief attacks nearly every witness who opposed it — bar one scientist ...
SUMMIT European Cannabis Insights Summit 2026 — Exclusive industry intelligence Register Now ...
SUMMIT European Cannabis Insights Summit 2026 — Exclusive industry intelligence Register Now ...
SUMMIT European Cannabis Insights Summit 2026 — Exclusive industry intelligence Register Now ...
SUMMIT European Cannabis Insights Summit 2026 — Exclusive industry intelligence Register Now ...
SUMMIT European Cannabis Insights Summit 2026 — Exclusive industry intelligence Register Now ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results